BIO-key International is trading at $2.67, with a -9.49% change, amid broader technology-sector weakness.
- No confirmed company-specific announcement on October 16 explains the decline.
- The October 13 government-agency customer announcement preceded the recent sharp rise, but available reporting does not link it to today’s drop.
- Reporting described renewed pressure on technology stocks amid concerns about AI investment and borrowing costs. At the time of this alert, the Nasdaq was down 1.36% and the S&P 500 was down 0.62%.